CN EN
CN EN

Please enter the information you want to find

Hot key words：
Hyaluronidase xxx
News Center News Center

News Center

2025.04.29

【News】 Bao Pharma’s “KJ103 for Injection” Receives NMPA Approval for New Indication Clinical Trial

View details
【News】 Bao Pharma’s “KJ103 for Injection” Receives NMPA Approval for New Indication Clinical Trial
[News] BaoPharma’s KJ015 Injection (Subcutaneous) Receives Clinical Trial Approval from the NMPA
2025.02.13

[News] BaoPharma’s KJ015 Injection (Subcutaneous) Receives Clinical Trial Approval from the NMPA

View details
[News] Bao Pharma Completes Pharmaceutical Excipient Registration for Hyaluronidase
2024.11.21

[News] Bao Pharma Completes Pharmaceutical Excipient Registration for Hyaluronidase

View details
[News] KJ103 (Ricefidase) Designated as a Breakthrough Therapy
2024.11.20

[News] KJ103 (Ricefidase) Designated as a Breakthrough Therapy

View details
[News] Bao Pharma’s “KJ103 for Injection” Receives Clinical Trial Approval from NMPA
2024.08.22

[News] Bao Pharma’s “KJ103 for Injection” Receives Clinical Trial Approval from NMPA

View details
12